Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (80)

2024

  1. Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study

    Circulation Research, Vol. 134, Núm. 4, pp. 411-424

  2. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

    Journal of Endocrinological Investigation

  3. Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients

    Cytokine, Vol. 177

  4. Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z)

    British Journal of Cancer

  5. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  6. Difficulties on the access to innovative targeted therapies for lung cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 597-612

  7. Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach

    Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326

  8. Examining the Forearm Intersection through Palpation and Ultrasonography

    Diagnostics, Vol. 14, Núm. 1

  9. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline

    British Journal of Pharmacology

  10. Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design

    Nefrologia

  11. In Vivo Detection of Staphylococcus aureus Infections Using Radiolabeled Antibodies Specific for Bacterial Toxins

    International Journal of Biomedical Imaging, Vol. 2024

  12. Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

    British Journal of Cancer, Vol. 130, Núm. 8, pp. 1402-1413

  13. Isolated hypoaldosteronism is a cause of hypovolemic but not euvolemic hyponatremia

    Endocrine Connections, Vol. 13, Núm. 3

  14. MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension

    Science advances, Vol. 10, Núm. 3, pp. eadk6524

  15. Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus

    Nature Communications, Vol. 15, Núm. 1

  16. Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient

    Archivos de Bronconeumologia

  17. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798

  18. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  19. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776

  20. Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document

    Endocrine